Yehong Zhang Joins Aetna as General Manager, Greater China
SHANGHAI Aetna (NYSE: AET), a leading global diversified health care solutions company, has named Yehong Zhang, Ph.D., as general manager, Greater China. Based in Aetna’s offices in Shanghai, Dr....
View Article月1回投与の持続性注射剤「Abilify Maintena®」(エビリファイ メンテナ)成人統合失調症の維持治療を適応として欧州承認
東京 (ビジネスワイヤ) — 大塚製薬株式会社(本社:東京都千代田区、代表取締役社長:岩本太郎、以下「大塚製薬」)とH.ルンドベックA/S(本社:デンマーク、コペンハーゲン、CEO:ウルフ・ウインバーグ、以下「ルンドベック社」)は、欧州委員会(EC)より、経口の「エビリファイ」によって状態が安定した成人統合失調症の維持治療薬として「Abilify Maintena」(エビリファイ...
View ArticleOtsuka and Lundbeck’s Once-Monthly Abilify Maintena® (Aripiprazole) Now...
TOKYO & COPENHAGEN, Denmark Otsuka Pharmaceutical Co., Ltd. (Otsuka) and H. Lundbeck A/S (Lundbeck) today announced marketing authorization approval from the European Commission for Abilify...
View ArticleMerck Consumer Health Turnaround on Track
DARMSTADT, Germany Merck’s Consumer Health division has made substantial progress in driving the turnaround of the business, raising profitability levels to those of other global over-the-counter...
View Articleロス大学獣医学部、研究所の上席研究員を任命
Smart Multimedia Gallery Dr. Michel Vandenplas, senior scientist at Ross University School of Veterinary Medicine (Photo: Business Wire) View and Share Photo Download Small Dr. Michel Vandenplas,...
View Article张业泓加入AETNA任大中华区总经理
上海 (美国商业资讯)–全球领先的多元化医疗健康方案供应商Aetna(NYSE:AET)任命张业泓博士为新任大中华区总经理。张博士的办公地点将在上海,主要负责中国大陆、香港、澳门及台湾地区的公司发展。该任命当即生效。 “业泓拥有极为丰富的管理经验,对中国的医疗系统、法规和改革力度都有很深的了解。”Aetna International 的主席Richard di...
View ArticleZRG Partners Inc. Releases Third Quarter 2013 Life Sciences Hiring Index
WEST ORANGE, N.J. ZRG Partners Inc. announces the results of its third quarter Global Life Sciences Hiring Index. Q3 reflects an overall decline of 5.1%, despite the Outsourcing and Services sectors...
View Articleバンシブ・メディカル・テクノロジーズとケアフュージョンが抗菌性被覆材の事業で契約締結
シカゴ (ビジネスワイヤ) — バンシブ・メディカル・テクノロジーズとケアフュージョン・コーポレーション(NYSE:CFN)は本日、血管アクセスに使用するバンシブの抗菌性クロルヘキシジングルコネート(CHG)粘着剤技術BeneHold™のライセンシング・販売に関し、米国、カナダ、メキシコにおける独占的契約を締結したと発表しました。...
View ArticleOxford Immunotec Global PLC宣布IPO定价
英国牛津和马萨诸塞州马尔伯勒 (美国商业资讯)–Oxford Immunotec Global PLC (NASDAQ: OXFD) (“公司”)...
View ArticleTaro Announces Commencement of Tender Offer to Repurchase up to $200 Million...
HAWTHORNE, N.Y. Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) announced today that it has commenced a modified “Dutch auction” tender offer to repurchase up to $200...
View ArticleArrowhead Submits Application to Begin Phase 2a Trial of ARC-520 for the...
PASADENA, Calif. Arrowhead Research Corporation (NASDAQ:ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it recently filed an application for approval...
View ArticleTransgene Supports Proposed Acquisition of Jennerex by SillaJen
STRASBOURG, France Regulatory News: Transgene SA (Paris:TNG) (NYSE-Euronext: TNG) said today that it welcomed the announcement by SillaJen, Inc. of its intention to acquire Jennerex, Inc. and has...
View Articleオックスフォード・イムノテック・グローバル、新規株式公開価格を発表
英オックスフォード、米マサチューセッツ州マールボロ ビジネスワイヤ) — オックスフォード・イムノテック・グローバル(NASDAQ:...
View ArticleEverest Group Recognizes HCL as a Leader and Star Performer in the Life...
SUNNYVALE, Calif. & NOIDA, India HCL Technologies, a leading global IT services company today announced that it has been recognized as a “Leader” and “Star Performer” category in life sciences...
View ArticleNew on the Voice of Russia: Research Findings Indicate a Higher Risk of...
NEW YORK After the 2011 disaster at the Fukushima nuclear plant in Japan, little attention was paid to how the radiation leaks can affect the health of children living in the U.S. Joseph Mangano,...
View Article沙特阿拉伯主办脑研究和个体化医疗国际论坛
沙特阿拉伯吉达 (美国商业资讯)–沙特阿拉伯王国将主办领先的脑研究和个体化医疗国际论坛:脑论坛(The Brain Forum)——挑战未来。该论坛在中东首次创办;沙特阿拉伯王国热忱欢迎来自全世界脑研究及相关神经科学技术领域中思想最先进的思想领袖。该论坛涵盖阿尔茨海默病、帕金森病和癫痫等论题,将于12月3-4日在吉达(Jeddah)的Laylati Hall举办。脑论坛由W...
View Articleサウジアラビアが脳研究と個別化治療に関する国際フォーラムを開催
サウジアラビア・ジッダ (ビジネスワイヤ) — サウジアラビア王国は脳研究と個別化治療をテーマとする有数の国際フォーラム「ブレイン・フォーラム –...
View ArticleData from Final Cohort of Patients in Patrys Multiple Myeloma Clinical Trial
MELBOURNE, Australia Patrys Limited (ASX:PAB), a clinical stage biotechnology company has announced that updated results from its PAT-SM6 Phase I/IIa clinical trial in multiple myeloma (MM) will be...
View ArticleWiley to Provide Emergency Access to Medical Literature in Support of Typhoon...
HOBOKEN, N.J. Wiley will offer free access to medical literature in support of Typhoon Haiyan relief efforts to those affected by the disaster and to those providing assistance to the affected...
View ArticleAsia’s Leading Environmental Show IE expo 2014 Expands Sector for Air...
MUNICH During the next few years, environmental protection and improving the quality of the air in particular are one of the key topics facing the Chinese government. To adapt itself to the special...
View Article